Publications — Radcliffe Department of Medicine

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Cryoprecipitate transfusion in trauma patients attenuates hyperfibrinolysis and restores normal clot structure and stability: Results from a laboratory sub-study of the FEISTY trial

Morrow GB. et al, (2022), Critical Care, 26

The suboptimal fibrinolytic response in COVID-19 is dictated by high PAI-1.

Whyte CS. et al, (2022), J Thromb Haemost

Removing plasmin from the equation - Something to chew on….

Morrow GB. and Mutch NJ., (2021), J Thromb Haemost

A serpin with a finger in many PAI’s: PAI-1’s central function in thromboinflammation and cardiovascular disease

MORROW G. et al, (2021), Frontiers in Cardiovascular Medicine

Fibrinogen Replacement Therapy for Traumatic Coagulopathy: Does the Fibrinogen Source Matter?

Morrow GB. et al, (2021), Int J Mol Sci, 22

Characterisation of a novel thrombomodulin c.1487delC,p.(Pro496Argfs*10) variant and evaluation of therapeutic strategies to manage the rare bleeding phenotype.

Morrow GB. et al, (2021), Thromb Res, 197, 100 - 108

Exposure of plasminogen and the novel plasminogen receptor, Plg-RKT, on activated human and murine platelets

Whyte CS. et al, (2020), Blood

Coagulation status of critically ill patients with and without liver disease assessed using a novel thrombin generation analyzer.

Morrow GB. et al, (2020), J Thromb Haemost, 18, 1576 - 1585

Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19.

Whyte CS. et al, (2020), J Thromb Haemost

Functional plasminogen activator inhibitor 1 is retained on the activated platelet membrane following platelet activation

Morrow GB. et al, (2019), Haematologica, haematol.2019.230367 - haematol.2019.230367

Coagulation status of critically ill patients with liver disease assessed using a novel thrombin generation analyser

Morrow GB. et al, (2019), BRITISH JOURNAL OF HAEMATOLOGY, 185, 137 - 137

UTP is not a biased agonist at human P2Y11 receptors

Morrow GB. et al, (2014), Purinergic Signalling, 10, 581 - 585

Include forthcoming?